Noubar Afeyan
Signal active
Founder & CEO
Bio
Noubar Afeyan is the Founder and CEO of Flagship Pioneering. He previously worked at Omega Therapeutics as a Co-Founder and Chairman. Noubar Afeyan attended the Massachusetts Institute of Technology.
Location
Cambridge, Massachusetts, United States, North America
Social
Primary Organization
Flagship Pioneering
Founded
2000
Investment
274
Lead investment
96
Exits
66
Employees
5001-10000
Industry
Venture Capital, Finance, Biotechnology, Business Development, Health Care
Jobs history
33
Ampersand Biomedicines
Co-founder and Chairman
2022 - Current
Codiak Biosciences
Co-Founder and Board Member
2015 - 2017
PerSeptive Biosystems
CEO and Founder
1989 - 1998
Agenus
Board Member and Founding Investor
1996 - 2007
Epitome Biosystems
Co-founder
2003 - 2005
Massachusetts Institute of Technology
Member Board of Trustees
2016 - Current
Cobalt Biomedicine
Board Member & Co-Founder
2016 - 2019
Aurora Prize
Co-Founder & Board Member
2014 - Current
Repertoire Immune Medicines
Board Member & Co-Founder
2016 - 2021
Apriori Bio
Co-Founder & Chairman
2021 - Current
Tessera Therapeutics
Co-Founder & Board Member
2018 - Current
Adnexus
Board Member & Founder
2003 - 2008
Celera
Co-Founder
1998 - 1999
Valo Health
Founding Chairman
2018 - 2020
Cellarity
Co-Founder & Chairman
2018 - 2021
ProFound Therapeutics
Founding Chairman
2021 - Current
Boston Symphony Orchestra
Member Board of Trustees
2008 - Current
Selventa
Board Member & Founder
2002 - 2007
Color Kinetics, Incorporated
Board Member & Founding Investor
1997 - 2008
Montai Health
Co-Founder & Board Member
2019 - 2023
Alltrna
Founding Chairman
2018 - 2023
CIBO Technologies
Co-Founder & Board Member
2015 - 2017
T2 Biosystems
Board Member & Founding Investor
2006 - 2009
Exact Sciences
Board Member & Founding Investor
1995 - 2001
Generate Biomedicines
Board of Director
Invalid date - Current
Apriori Bio
Board Member
Invalid date - Current
Omega Therapeutics
Co-Founder and Chairman
2016 - 2023
Generate Biomedicines
Chairman and Co-Founder
2018 - Current
Harvard Business School
Visiting Lecturer
2018 - Current
Laronde
Co-founder and Chairman of the Board
2017 - 2022
Ring Therapeutics
Co-Founder & Chairman
2018 - 2021
Indigo
Co-Founder and Board Member
2024 - Current
Cygnal Therapeutics
Founder and CEO / Founding Chairman, Flagship Pioneering / Cygnal Therapeutics
2016 - 2019
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Noubar Afeyan is the Founder & CEO at Flagship Pioneering, based in United States, North America. With a background in Venture Capital, Noubar Afeyan has a rich history of leadership and innovation. Noubar Afeyan studied Ph.D. Biochemical Engineering @ Massachusetts Institute of Technology. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
N/A
Number of investment
1
Number of exits
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
27
| Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
|---|---|---|---|---|
| Aug 09, 2023 | Alltrna | Series B - Alltrna | Flagship Pioneering | 109.0M |
| Sep 15, 2023 | Generate Biomedicines | Series C - Generate Biomedicines | Flagship Pioneering | 273.0M |
| Nov 21, 2023 | Quotient Therapeutics | Seed Round - Quotient Therapeutics | Flagship Pioneering | 50.0M |
| May 07, 2024 | Prologue Medicines | Series A - Prologue Medicines | Flagship Pioneering | 50.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.